DEXCOM INC Financing Cash Flow 2009-2026 | DXCM
Beta
What is financing cash flow?
Financing cash flow represents cash from or used in financing activities, including borrowing, repaying debt, issuing or repurchasing stock, and paying dividends.
What is DEXCOM INC's current financing cash flow?
DEXCOM INC (DXCM) annual financing cash flow for 2025 was $-1.69B, a 129.50% decline from 2024. DEXCOM INC financing cash flow for the quarter ending March 31, 2026 was $-25.0M.
What was DEXCOM INC's financing cash flow in 2024?
DEXCOM INC annual financing cash flow for 2024 was $-734.8M, a 130.63% decline from 2023.
What was DEXCOM INC's financing cash flow in 2023?
DEXCOM INC annual financing cash flow for 2023 was $-318.6M, a 42.33% increase from 2022.
Financing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGRN/A
FY2020
$912.1M
→
FY2025
$-1.69B
0910111213141516171819202122232425
5 years selected
Financing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-1.69B | -129.5% | 10-K |
| FY2024 | $-734.8M | -130.6% | 10-K |
| FY2023 | $-318.6M | +42.3% | 10-K |
| FY2022 | $-552.5M | -5412.5% | 10-K |
| FY2021 | $10.4M | -98.9% | 10-K |
| FY2020 | $912.1M | +8424.3% | 10-K |
| FY2019 | $10.7M | -98.5% | 10-K |
| FY2018 | $710.4M | +78.0% | 10-K |
| FY2017 | $399.1M | +4827.2% | 10-K |
| FY2016 | $8.1M | -51.8% | 10-K |
| FY2015 | $16.8M | -22.9% | 10-K |
| FY2014 | $21.8M | +84.7% | 10-K |
| FY2013 | $11.8M | +15.7% | 10-K |
| FY2012 | $10.2M | -86.3% | 10-K |
| FY2011 | $74.2M | +6.6% | 10-K |
| FY2010 | $69.6M | +56.8% | 10-K |
| FY2009 | $44.4M | - | 10-K |
Company: DEXCOM INCTicker: DXCMSector: HealthcareIndustry: Surgical & Medical Instruments & ApparatusView company profile →